Jianerkang Medical Co.,Ltd. (SHA:603205)
China flag China · Delayed Price · Currency is CNY
20.63
-0.13 (-0.63%)
At close: Nov 17, 2026

Jianerkang Medical Income Statement

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Revenue
1,0971,0231,0421,0321,090780.16
Other Revenue
1.591.594.021.42.771.88
1,0991,0241,0461,0341,093782.04
Revenue Growth
11.20%-2.04%1.18%-5.46%39.79%-51.83%
Cost of Revenue
827.9781.76812.39802.61834.8600.08
Gross Profit
271.03242.62233.37230.92258.43181.97
Selling, General & Admin
77.4775.0762.8754.3157.1351.42
Research & Development
42.840.6840.7236.5935.328.64
Other Operating Expenses
12.539.049.627.899.096.43
Operating Expenses
123.94124.37112.73104.73116.0780.98
Operating Income
147.09118.25120.64126.18142.36100.98
Interest Expense
-1.5-1.16-0.01-0.65-1.66-2.07
Interest & Investment Income
12.214.167.614.352.670.45
Currency Exchange Gain (Loss)
-6.24-6.246.298.6728.55-7.17
Other Non Operating Income (Expenses)
-16.87-0.36-0.2-0.25-0.23-0.45
EBT Excluding Unusual Items
134.69124.64134.34138.31171.6991.74
Gain (Loss) on Sale of Investments
0.92---16.68--
Gain (Loss) on Sale of Assets
0.090.560.430.03-3.020.13
Asset Writedown
0.89-0.13-0.07-0.07-0.07-0.12
Other Unusual Items
4.341.232.7820.689.2457.88
Pretax Income
141126.38137.69142.62177.83149.63
Income Tax Expense
17.5514.9417.4819.0820.4918
Net Income
123.45111.44120.22123.55157.34131.63
Net Income to Common
123.45111.44120.22123.55157.34131.63
Net Income Growth
19.66%-7.31%-2.69%-21.48%19.53%-65.75%
Shares Outstanding (Basic)
156157124117117117
Shares Outstanding (Diluted)
156157124117117117
Shares Change
2.00%26.64%5.71%0.21%-0.01%12.43%
EPS (Basic)
0.790.710.971.051.341.13
EPS (Diluted)
0.790.710.971.051.341.13
EPS Growth
17.30%-26.80%-7.95%-21.64%19.54%-69.53%

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
86.7788.81101.3573.6296.721.96
Free Cash Flow Per Share
0.560.570.820.630.830.19
Dividend Per Share
0.2500.2500.351---
Dividend Growth
-28.78%-28.78%----
Gross Margin
24.66%23.69%22.32%22.34%23.64%23.27%
Operating Margin
13.38%11.54%11.54%12.21%13.02%12.91%
Profit Margin
11.23%10.88%11.50%11.95%14.39%16.83%
Free Cash Flow Margin
7.90%8.67%9.69%7.12%8.85%2.81%
EBITDA
192.92162.72163.31167.13179.2133.4
EBITDA Margin
17.56%15.88%15.62%16.17%16.39%17.06%
D&A For EBITDA
45.8344.4842.6740.9536.8432.41
EBIT
147.09118.25120.64126.18142.36100.98
EBIT Margin
13.38%11.54%11.54%12.21%13.02%12.91%
Effective Tax Rate
12.45%11.82%12.69%13.38%11.52%12.03%
Revenue as Reported
1,0991,0241,0461,0341,093782.04
Advertising Expenses
-2.153.142.162.843.15